Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy

Moritz Stolla, Lucia Stefanini, R. Claire Roden, Massiel Chavez, Jessica Hirsch, Teshell Greene, Timothy D. Ouellette, Sean F. Maloney, Scott L. Diamond, Mortimer Poncz, Donna S. Woulfe, Wolfgang Bergmeier

Blood (2011) 117 (3): 1005–1013.

https://doi.org/10.1182/blood-2010-07-297713

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

The Signaling Molecule CalDAG-GEFI Represents a Novel Target for Antithrombotic Therapy.

Moritz Stolla, M.D., Lucia Stefanini, Ph.D., Jessica Hirsch, Claire Roden, Timothy Daniel Ouellette, BS, Mortimer Poncz, M.D., Wolfgang Bergmeier, Ph.D.

Blood (2009) 114 (22): 1077.

https://doi.org/10.1182/blood.V114.22.1077.1077

Published: 2009

Journal Articles

Visualizing the Molecular and Cellular Basis of Heparin Induced Thrombocytopenia.

Lubica Rauova, MD, PhD, Jessica Hirsch, Teshell Greene, Chandrasekaran Nagaswami, Douglas B. Cines, MD, John W. Weisel, PhD, Mortimer Poncz, MD

Blood (2009) 114 (22): 228.

https://doi.org/10.1182/blood.V114.22.228.228

Published: 2009

Journal Articles

Strategies to Enhance the Efficacy of Platelet-Derived Factor (F) VIII: Studies with Inactivation Resistant FVIII (IR8) and Canine FVIII in Hemophilia A Mice.

Teshell K. Greene, BS, Cheng Wang, Jessica Hirsch, BS, Hongzhi Miao, Steven W. Pipe, MD, M. Anna Kowalska, PhD, Mortimer Poncz, MD

Blood (2009) 114 (22): 3496.

https://doi.org/10.1182/blood.V114.22.3496.3496

Published: 2009

Journal Articles

Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel αIIb-specific αIIbβ3 antagonist

Robert Blue, M. Anna Kowalska, Jessica Hirsch, Marta Murcia, Christin A. Janczak, Amanda Harrington, Marketa Jirouskova, Jihong Li, Rudy Fuentes, Michael A. Thornton, Marta Filizola, Mortimer Poncz, Barry S. Coller

Blood (2009) 114 (1): 195–201.

https://doi.org/10.1182/blood-2008-08-169243

Published: 2009

Includes: Multimedia, Supplemental data

NARROW

The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy

The Signaling Molecule CalDAG-GEFI Represents a Novel Target for Antithrombotic Therapy.

Visualizing the Molecular and Cellular Basis of Heparin Induced Thrombocytopenia.

Strategies to Enhance the Efficacy of Platelet-Derived Factor (F) VIII: Studies with Inactivation Resistant FVIII (IR8) and Canine FVIII in Hemophilia A Mice.

Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel αIIb-specific αIIbβ3 antagonist

Email alerts

ASH Publications

American Society of Hematology

The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy

The Signaling Molecule CalDAG-GEFI Represents a Novel Target for Antithrombotic Therapy.

Visualizing the Molecular and Cellular Basis of Heparin Induced Thrombocytopenia.

Strategies to Enhance the Efficacy of Platelet-Derived Factor (F) VIII: Studies with Inactivation Resistant FVIII (IR8) and Canine FVIII in Hemophilia A Mice.

Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel αIIb-specific αIIbβ3 antagonist

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only